Article info
Inflammation and inflammatory bowel disease
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
- Professor W Kruis, Evangelisches Krankenhaus Kalk, Buchforststr. 2, D-51103 Köln (Cologne), Germany
Citation
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
Publication history
- Accepted March 12, 2001
- First published December 1, 2001.
Online issue publication
December 01, 2001
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
British Society of Gastroenterology